MedTrace Logo

Spinal Cord Stimulation in Chemotherapy Induced Neuropathy

NCT03764514 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2024-09-24

No results posted yet for this study

Summary

This is an observational based pilot study evaluating the use of spinal cord stimulators for the treatment of chemotherapy induced peripheral neuropathy will lead to an increase in quality of life and decrease in pain.

Conditions

  • Chemotherapy-induced Peripheral Neuropathy

Interventions

DEVICE

Spinal Cord Stimulator

Permanent Implantation

Sponsors & Collaborators

  • Prisma Health-Upstate

    lead OTHER

Principal Investigators

  • Joshua Smith, MD · Prisma Health-Upstate

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-03
Primary Completion
2022-05-03
Completion
2022-05-03
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03764514 on ClinicalTrials.gov